SBI Securities’s Valion Bio VBIO Stock Holding History

SBI Securities’s Portfolio VBIO Stock Details VBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$148	Buy	53 +52	+5,200%	+$312	﹤0.01%	3489
2026 Q2	$8	Hold	1	–	–	﹤0.01%	3942
2026 Q1	$14	Hold	1	–	–	﹤0.01%	3815
2025 Q4	$23	Hold	1	–	–	﹤0.01%	3756
2025 Q3	$46	Hold	1	–	–	﹤0.01%	3745
2025 Q2	$66	Hold	1	–	–	﹤0.01%	3657
2025 Q1	$41	Hold	1	–	–	﹤0.01%	3699
2024 Q4	$106	Buy	+1	New	+$116	﹤0.01%	3437

Other funds holding VBIO

Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return

Danske Bank Copenhagen K, Denmark $50.1B AUM 35.17% 1-Year Est. Return

SBI Securities's VBIO Position: Q3 2026 in Review

SBI Securities increased its Valion Bio (VBIO) stake by 5,200% in Q3 2026, buying an estimated $312 and bringing the position to 53 shares worth $148. The position accounts for ﹤0.01% of the portfolio, ranked #3489.

SBI Securities first reported a position in VBIO in Q4 2024 and has held it in 8 quarters since. 3 funds tracked by Wall St. Rank hold VBIO as of Q3 2026.

SBI Securities held 53 shares of Valion Bio worth $148 as of Q3 2026.
SBI Securities bought 52 Valion Bio shares in Q3 2026, an estimated $312.
Valion Bio made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #3489 holding.
SBI Securities first reported a position in Valion Bio in Q4 2024 and has held it in 8 quarters since.
3 funds tracked by Wall St. Rank held Valion Bio as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.